The impact of rurality and substance use on young people at ultra high risk for psychosis by Stain, Helen et al.
  
 
© 2017 Wiley. This is the peer reviewed version of the following 
article: 
Stain, H.J., Halpin, S.A., Baker, A.L., Startup, M., Carr, V.J., Schall, U., 
Crittenden, K., Clark, V., Lewin, T.J., Bucci, S. (2017) Impact of rurality 
and substance use on young people at ultra high risk for psychosis. 
Early intervention in psychiatry. (Published online ahead of print 26 
Jul 2017). 
which has been published in final form at 
https://doi.org/10.1111/eip.12437 This article may be used for non-
commercial purposes in accordance with Wiley Terms and 
Conditions for Self-Archiving. 
 
 
Abstract 
Objective: Longitudinal research into early intervention for youth at ultra high risk 
(UHR) for psychosis demonstrates beneficial outcomes including increased treatment 
compliance and greater participation in education and the workforce. Despite known 
barriers for rural youth accessing mental health services, research comparing urban 
and rural UHR youth is lacking. The study included an examination of the impact of 
substance use on functioning of UHR youth. Method: Youth aged 12-25 years were 
recruited from the urban area of Newcastle or the rural area of Orange, New South 
Wales, Australia, and identified as UHR by the Comprehensive Assessment of At Risk 
Mental States (CAARMS). Rural and urban youth were compared on clinical profiles, 
social and occupational functioning, and substance use. Results: The rural youth 
showed different help seeking behaviours and had greater functional impairment than 
urban youth. Substance use was common across the sample of 57 youth (mean age 
16.5 years, 56% female) and a history of hazardous substance use was associated with 
higher levels of depression. Rural youth (n=32) were more likely than urban youth to 
be taking antidepressants at baseline (44% compared to 16%). Conclusion: Different 
patterns of help seeking by rural UHR youth suggest a need for greater access to 
psychosis informed primary care early intervention services. Interventions should 
target functional decline to prevent adverse outcomes such as reduced community 
participation and unemployment. In addition, interventions for substance use should 
be a priority for UHR youth, who should also be screened and monitored for 
depressive symptoms and treated for depression if indicated. 
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Background 
There is substantial geographical variability in the burden of ill-health between 
metropolitan and rural regions in many countries (1, 2). For example, Australian and 
international reports have found poorer physical health, increased socio-economic 
disadvantage, and poorer access to health and social services in rural and remote areas 
(3). In particular, Australian rural youth (18-24 years) experience lower social support 
and are significantly more likely than urban youth to consume alcohol at hazardous 
levels (up to 37% of rural youth), and have significantly higher rates of death by injury 
(up to 5 times their urban counterparts) or suicide (4). A significant decline in 
functioning in adolescence occurs for young people at risk of developing psychosis or 
with a first episode of psychosis (FEP; 5) and reduced participation in school, 
vocational training or employment is an important risk factor for social exclusion (6, 7). 
Despite the health inequalities of rural residency, there is a lack of research examining 
the clinical and functioning profiles of young rural people at risk for developing 
psychosis. 
In recent decades there have been assertive attempts to identify individuals at ultra 
high risk (UHR) of developing psychotic disorders. Three common criteria are often 
used within UHR samples, identifying individuals with a recent decline in functioning 
along with either genetic vulnerability, attenuated positive symptoms and/or frank 
intermittent psychotic symptoms (8). Assessment for UHR is usually conducted using a 
semi-structured clinical interview such as the Comprehensive Assessment of At Risk 
Mental States (CAARMS; 8). No known studies have investigated differences in 
presentation and outcomes of rural versus urban youth deemed at UHR of psychosis. 
Despite our knowledge of the challenges faced by rural youth such as reduced access 
to services and limited social support, there is a paucity of research into the 
management and outcomes of early psychosis in rural areas. An Australian survey of 
mental health service directors found that rural and remote public mental health 
services showed the lowest levels of early psychosis intervention implementation (9). 
The few published studies of early psychosis intervention in rural settings tend to 
describe service models rather than provide clinical information about the youth 
attending the services (10). As a result, little is known about rural youth at UHR of 
psychosis. Youth from rural and urban areas often have different demographic 
characteristics, and rural youth have reduced access to specialist mental health 
services, and greater distances to travel to reach services (10, 11). These factors 
present possible barriers to early identification of UHR youth in the rural environment. 
Therefore, it is timely to consider the similarities and differences between rural and 
urban youth deemed at UHR of psychosis. 
Adolescents in rural Australia have been shown to be at greater risk of alcohol use than 
urban youth (12) and substance use is associated with poor health outcomes for those 
experiencing a first episode of psychosis (13). In the UHR population, higher levels of 
substance use are associated with more severe symptoms (14). Specifically, a dose-
response relationship between heavy cannabis use and transition to psychosis in UHR 
individuals was reported by a meta-analysis (15). Recent research has shown UHR 
individuals to have significantly higher rates of tobacco, alcohol and cannabis use than 
help seeking non-UHR individuals (16).  
The current study aimed to compare the demographic characteristics, substance use 
patterns, functioning and clinical presentations of rural and urban youth identified at 
UHR of psychosis. In addition, the study sought to examine the impact of substance 
use on functioning of UHR youth. The data were drawn from the baseline assessments 
of the DEPTh trial (17), a single blind randomised controlled trial comparing the 
effectiveness of cognitive behaviour therapy (CBT) and non-directive reflective 
listening (NDRL) in ameliorating ‘at risk mental states’ for psychosis and delaying or 
preventing transition to psychosis among UHR youth recruited from urban and rural 
locations. 
Method 
Participants 
Youth aged 12 – 25 years were recruited in the urban Newcastle region and the rural 
Orange region of New South Wales (NSW), Australia. For the urban site, youth were 
primarily recruited through the Psychological Assistance Service (PAS), an early 
psychosis clinical service established in 1997 with a focus on identification and 
treatment of young people at risk of psychosis (18, 19) (20). The rural site was located 
at the Centre for Rural and Remote Mental Health, a research unit of the University of 
Newcastle in the central west region of rural NSW. This site did not have access to a 
specialised early psychosis service and hence relied upon promotion of the research 
within health and non-health services to facilitate recruitment. Youth were eligible for 
the study if they: (i) were aged 12-25 years; (ii) resided within the Newcastle region of 
the Hunter New England Area Health Service (urban sample) or within a 170km radius 
(for accessibility for weekly therapy) of Orange in the Greater Western Area Health 
Service (rural sample); and (iii) met criteria for one or more of three ‘at risk mental 
states’ as defined by the Comprehensive Assessment of at Risk Mental States 
(CAARMS; 8). Recruitment for the rural and urban samples is illustrated in Figure 1. 
Youth were excluded from the study if they: (i) met criteria for a past or current DSM-
IV-TR psychotic disorder; (ii) had previously been prescribed anti-psychotic medication 
at a therapeutic level (considered a sign of transition); (iii) had an organic mental 
disorder or intellectual disability; (iv) were at serious suicidal or homicidal risk (they 
were eligible for inclusion once this risk was resolved); or (v) had an inadequate 
command of the English language (due to the verbal demands of therapy and 
assessment). The study was approved by the Human Research Ethics Committees of 
the participating institutions. 
INSERT FIGURE 1 HERE 
Procedure 
Participants meeting eligibility criteria for the DEPTh trial completed a baseline 
assessment. This assessment involved completing a series of clinical interviews with a 
registered psychologist with extensive experience providing assessment and treatment 
for UHR and FEP youth. Participants completed a range of reliable and valid measures, 
each widely used within clinical samples. In addition to demographic information, the 
following measures were completed at baseline. 
Mental health measures 
The Comprehensive Assessment of At-Risk Mental States (CAARMS; 8) is a semi-
structured interview used to determine whether individuals meet criteria for being at 
UHR of psychosis. There are three UHR groups defined by the CAARMS: (i) Group A -
trait and state risk factor (Trait) (genetic vulnerability due to having a schizotypal 
personality disorder, or a first-degree relative with a psychotic disorder); (ii) Group B - 
attenuated psychotic symptoms (APS) (sub-threshold, attenuated positive psychotic 
symptoms); and (iii) Group C - brief limited intermittent psychotic symptoms (BLIPS) 
(short episodes of frank psychotic symptoms that have resolved without treatment); with 
each group including chronic low or a significant decrease in functioning. 
The Structured Clinical Interview for DSM-IV – Clinical Version (SCID-CV: 21) is a semi-
structured interview that systematically assesses whether individuals meet diagnostic 
criteria for DSM-IV Axis I diagnoses. 
The Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present 
and Lifetime Version (K-SADS-PL: 22) is a semi-structured interview based on DSM-III-R 
and DSM-IV criteria, designed to assess current and previous episodes of 
psychopathology in children and adolescents. The K-SADS-PL was substituted for the 
SCID-CV to assess diagnoses for any participant younger than 18 years. 
The Brief Symptom Inventory (BSI: 23) is a self-report inventory in which individuals 
report the extent to which they have experienced a range of symptoms in the past 
week. The individual items contribute to nine subscales: somatisation, obsessive-
compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobia, paranoia, 
and psychoticism. In addition, the measure provides a Global Severity Index and a 
Positive Symptom Distress Index. 
Substance use measures 
The Opiate Treatment Index (OTI: 24) is a structured interview that systematically 
assesses the individual’s use of substances. For each substance, a Q-score is calculated 
that provides an estimate of the average number of use occasions per day during the 
past month. Hazardous substance use was defined as at least weekly use of any illicit 
drug or drinking 2 or more (females) or 4 or more (males) standard drinks a day. 
The Alcohol Use Disorders Identification Test (AUDIT: 25, 26) is a 10-item assessment 
used to assess an individual’s level of consumption and problems associated with 
alcohol use. A total score greater than 8 is indicative of likely hazardous or harmful 
alcohol use in adults, while a cut-score of 3 or 4 is suggested for adolescents The 
AUDIT was administered as an interview within the current study. 
The Cannabis Use Disorders Identification Test – Revised (CUDIT-R: 27) is an 8-item 
screener used to assess an individual’s cannabis use. A total score greater than 13 is 
indicative of likely presence of a current cannabis use disorder. The CUDIT-R was 
administered as an interview within the current study. 
Role function and well-being measures 
The Global Assessment of Functioning (GAF: 28) is a clinician-rated measure of social, 
occupational, and psychological functioning. Ratings are made on a scale from 0 to 
100, with high scores indicative of higher levels of global functioning. 
The Social and Occupational Functioning Assessment Scale (SOFAS: 29) is a clinician-
rated measure of social and occupational functioning. Ratings are made on a scale 
from 0 to 100, with high scores indicative of higher levels of functioning. 
The Rosenberg Self-Esteem Scale (30) is a 10-item self-report measure. Each item is 
rated on a 4-point Likert-type response scale, with high total scores associated with 
greater self-esteem. 
The Quality of Life Scale (QLS: 31) is a 21-item semi-structured interview. Domains 
assessed include interpersonal relations, instrumental role functioning, intrapsychic 
foundations, and common objects and activities. Each item is rated on a 7-point 
anchor system, with low scores associated with poorer quality of life. 
Data analysis 
Data were analysed using IBM SPSS statistical software (Version 22.0; Armonk, NY, 
USA). Two sets of comparisons are reported, based on recruitment location (urban vs. 
rural) and substance use history (no history vs. hazardous use); these two variables 
were relatively independent in the current sample (hazardous substance use history: 
urban, 40.0%; rural, 31.3%, p = 0.492). For the categorical outcome variables, simple χ2 
tests were used, while independent samples t-tests were used for the continuous 
outcome variables. The threshold for statistical significance was set at p< 0.05. 
Results 
Combined sample 
The demographic characteristics, CAARMS UHR criteria, and DSM diagnostic clusters 
within the sample are reported in Table 1.  
INSERT TABLE 1 HERE 
Three of the 60 youth who completed the assessment and randomisation 
subsequently declined to participate in the study. The final sample of 57 youth was 
predominantly female (58%) with a mean age of 16.5 years (range 12-25 years). The 
majority were still living in the family home (77%) and studying full time (56%). Around 
10% of the youth were engaged in casual or part-time employment while 19% 
reported being unemployed. There were no significant differences between the rural 
and urban samples on any of these demographic characteristics. Consistent with other 
UHR studies, the majority of youth met UHR criteria on the CAARMS for attenuated 
symptoms (81%) while 33% met familial risk criteria, and only 7% met the Brief Limited 
Intermittent Psychotic Symptom (BLIPS) criteria. The most commonly occurring DSM-
IV diagnoses in both urban and rural groups tended to be depressive (Major 
Depressive Disorder) and anxiety disorders. 
Rural and urban youth 
Whilst rural and urban youth were very similar on many variables, including gender, 
age, clinical symptoms, and CAARMS profiles, there were significant differences in 
previous contacts with care providers. A greater proportion of urban youth reported 
previous contacts with school counsellors and general practitioners than rural youth. 
Conversely, a greater proportion of rural youth were prescribed antidepressant 
medication (40.6%) compared to urban youth (16.0%). 
INSERT TABLE 2 HERE 
As shown in Table 2, functional impairment was significantly greater for rural than 
urban youth across most domains of measurement. Rural youth were more impaired 
than urban youth in role and social functioning as well as overall quality of life and 
global functioning. Overall, one third of the sample reported current alcohol and 
tobacco use. 
Substance use history 
Those with a history of hazardous substance use (n=20) were significantly older than 
those without such a history (n=37) and also reported worse depressive symptoms on 
the BSI; however, these subgroups tended to have similar diagnostic, mental health 
contacts, and social and global functioning profiles (see Tables 1 and 2). It is 
noteworthy that those with a history of hazardous substance use also had mean levels 
of alcohol use that fell within the risky or hazardous alcohol use level for adults on the 
AUDIT. Although there were no significant differences between urban and rural youth, 
the mean AUDIT score for the rural youth reached the cut-score for adolescents of 4. 
Discussion 
The current study aimed to compare the demographic characteristics, substance use 
patterns, and clinical presentations of rural and urban youth identified at UHR of 
psychosis. While there were no significant differences in demographic characteristics, 
UHR clinical presentations as defined by the CAARMS, or substance use, rural UHR 
youth differed from urban youth in patterns of help seeking, and prescribed 
medications as well as social and role functioning. 
Help-seeking behaviour was significantly different between rural and urban youth, 
with rural youth more likely to have sought help from community mental health 
services rather than primary health care. Urban youth predominantly accessed primary 
care services as has been shown in other UHR studies (32). This pattern was also 
reflected in referral sources such that rural youth were more likely than urban youth to 
have been referred to the trial by mental health services. These findings suggest there 
are differences in the types of care providers and treatment approaches available to 
rural youth. The greater reliance on tertiary mental health services by rural UHR youth 
in our trial may have arisen from lower intake thresholds for rural compared to urban 
community mental health services. A more likely explanation might be related to the 
limited availability of primary care in rural areas (33). In these circumstances, youth 
might have delayed accessing assistance for emergent mental health symptoms until 
they were acutely unwell and required tertiary care. 
In addition, the availability of specialist early psychosis services differed between the 
rural and urban recruitment sites. In the rural recruitment area there was no existing 
specialist early psychosis service. The DEPTh trial presented the rural community 
mental health team with an opportunity for their clients to access specialist early 
psychosis assessment and intervention. In contrast, the urban recruitment site 
occurred within an established early psychosis clinical service, and the high rate of 
referrals from general practitioners likely reflected existing clinical referral pathways. 
Despite there being no differences in diagnoses, with the predominant diagnoses for 
both rural and urban youth being mood or anxiety disorders, rural youth were 
significantly more likely to have been prescribed antidepressant medication than 
urban youth. This higher level of prescribing antidepressants may be related to the 
scarcity of allied health practitioners and non-government organisations within rural 
areas (11).The Outreach and Support in South London (OASIS) service showed that 
14% of UHR youth were prescribed antidepressants prior to accessing the service(34). 
While the OASIS study found the prescribing of antidepressants was associated with 
higher rates of depressive comorbidities in the sample, this was not the case for our 
sample. 
Functional impairment was significantly greater for rural than urban youth across all 
domains of measurement in our trial. This included social and role functioning thus 
indicating a negative impact on school and employment. Not surprisingly, then, the 
rural youth reported poorer quality of life than urban youth. Our previous research 
examining the impact of prolonged drought on the social context for a community 
sample of rural youth showed increasing levels of psychological distress associated 
with declines in social networks due to relocation of families out of the drought 
affected area(35). While impaired social and occupational functioning (30% drop in 
past 12 months) is a criterion for UHR status, the average level of functional 
impairment for our sample is consistent with other studies (36, 37). Impaired social 
functioning has been shown to be predictive of transition to psychosis (38) and 
impairment in UHR similar to that of FEP (39). As such, the greater social functioning 
decline in our rural, compared to urban, youth may indicate more proximal risk for 
transition to psychosis. 
This functional impairment is likely to have adverse outcomes into adulthood such as 
reduced community participation, employment and social inclusion. For our sample, 
this functional impairment of UHR rural youth may reflect delayed access to services 
given there were no differences in diagnostic profiles compared to urban UHR youth. A 
recent systematic review found that negative and disorganised symptoms and 
neurocognitive impairment are key drivers of functional impairment in the UHR 
population (40). This could be explored further in future research examining how 
negative symptoms or neurocognitive impairment may contribute to differences in 
functional impairment between rural and urban UHR youth. Compromised social 
functioning will impact on relationships with peers and family, engagement in 
education, and negotiation of help seeking for health and vocational needs (41). 
Compromised social functioning may also reduce opportunities for exploring 
alternative explanations for unusual thoughts and anomalous perceptual experiences 
(42). As such, early intervention services for rural youth could be enhanced by 
increasing the awareness by clinicians of UHR profiles and using the early psychosis 
model for early intervention service delivery (11) with a focus on improving 
functioning (40). 
Tobacco and other substance use was reasonably common in both rural and urban 
youth. Although not significant, the mean AUDIT score for the rural sample was higher, 
reaching the cut-off for problematic alcohol consumption among adolescents. A 
history of hazardous substance use was associated with higher levels of depression. 
Recently, Barrowclough and colleagues reported that heavier alcohol use was 
associated with higher levels of depression among an established psychosis sample 
(43). Similarly tobacco smoking has been associated with depression and cessation 
with improved mood (44). Thus, interventions for substance use among UHR urban 
and rural young people UHR should be a priority and should include screening and 
counselling to reduce tobacco, alcohol, cannabis and other drug use and depressive 
symptoms. 
Strengths and limitations 
Consistent with other studies of UHR youth (39), there were difficulties recruiting to 
the trial with 25% fewer participants than planned and thus the trial was 
underpowered. While the trial utilised a robust design with an active control condition, 
the small sample may have reduced the ability to detect group differences. The 
analysis allowed for an examination of the impact of factors such as comorbid 
disorders on functioning but contextual factors such as socioeconomic status or social 
isolation were not examined in the dataset. 
Conclusion 
Different patterns of help seeking by rural UHR youth indicate a need for greater 
access to psychosis informed primary care services, which is critical to prevent 
impaired functioning and reduced quality of life. Importantly, interventions should 
target functional decline to prevent adverse outcomes such as reduced community 
participation and unemployment. In addition, interventions for tobacco, alcohol, 
cannabis and other substance use should be a priority for UHR youth, who should also 
be screened and monitored for depressive symptoms and treated for depression if 
indicated. Further research is warranted to explore early intervention models to 
enhance access to care for rural UHR youth and to explore the mechanisms for the 
greater functional impairment of rural UHR youth. 
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Table 1. Socio-demographic and diagnostic comparisons based on location and substance use history for ultra high risk youth (N=57) 
 
Characteristic Location  Substance Use History 
Urban 
(n=25) 
Rural 
(n=32) 
Combined 
(n=57) 
(Urban vs. 
Rura) p 
 No history 
(n=37) 
Hazardous Use  
(n=20) 
p 
Gender - % Female 64.0% 56.3% 57.9%   62.2% 55.0%  
Mean age (s.d.) 17.2 (3.03) 15.87 (2.76) 16.46 (2.93)   15.84 (2.63) 17.60 (3.17) * 
Current Status         
Working 16.0% 9.4% 12.3%   10.8% 15.0%  
Studying 60.0% 65.6% 63.1%   67.6% 55.0%  
Neither 24.0% 25.0% 24.6%   21.6% 30.0%  
Past Mental Health Contact         
School counsellor 48.0% 18.8% 31.6% *  32.4% 30.0%  
General practitioner 60.0% 25.0% 40.4% **  40.5% 40.0%  
Mental health professional 48.0% 62.5% 56.1%   64.9% 40.0%  
Other 24.0% 31.3% 28.1%   21.6% 40.0%  
CAARMS UHR Criteria         
Familial 28.0% 37.5% 33.3%   35.1% 30.0%  
Attenuated 72.0% 87.5% 80.7%   78.4% 85.0%  
BLIPS 3.1% 12.0% 7.0%   8.1% 5.0%  
Diagnostic cluster (SCID / K-SADS)         
Depression 40.0% 28.1% 33.3%   32.4% 35.0%  
Anxiety 40.0% 28.1% 33.3%   35.1% 30.0%  
Substance abuse 16.0% 6.3% 10.5%   0.0% 30.0% n/a 
Behavioural problem 12.0% 15.6% 14.0%   16.2% 10.0%  
Antidepressant medication 16.0% 40.6% 29.8% *  29.7% 30.0%  
CAARMS: Comprehensive Assessment of At Risk Mental States; SCID: Structured Clinical Interview for DSM Axis I Disorders; K-SADS: Kiddie-
Schedule for Affective Disorders and Schizophrenia. Statistical comparisons: χ2 for categorical variables, and t-tests for continuous variables. 
*p<.05; **p<.01; n/a for variables associated with sub-group definitions. 
  
Table 2. Current functioning comparisons based on location and substance use history for ultra high risk youth (N=57) 
 
Current Functioning 
 
Location  Substance Use History 
Urban 
(n=25) 
Rural 
(n=32) 
p  No history 
(n=37) 
Hazardous Use 
(n=20) 
p 
Current Substance Use        
OTI – Tobacco 2.89 (6.75) [8.68] 3.07 (6.26) [7.92]   1.45 (5.23) [7.68] 6.15 (7.56) [8.52] n/a 
OTI – Alcohol 0.63 (1.59) [1.89] 0.92 (3.03) [2.60]   0.07 (0.31) [0.44] 2.28 (4.00) [3.16] n/a 
OTI – Cannabis  0.00 (0.01) [0.04] 0.82 (3.69) [12.67]   0.00 (0.00) 1.41 (4.81) [8.46] n/a 
OTI – Polydrug Score 0.75 (0.99) 0.87 (0.99)   0.35 (0.59) 1.78 (0.94) n/a 
AUDIT 1.96 (5.70) 4.37 (8.25)   0.68 (1.73) 8.61 (10.74) n/a 
CUDIT-R 0.73 (3.41) 1.26 (4.30)   0.00 (0.00) 3.44 (6.68) n/a 
Self-Esteem Scale 26.00 (1.00) 22.34 (4.85)   23.13 (4.40) 21.56 (5.64)  
Quality of Life Scale 85.57 (19.51) 64.81 (23.91) ***  71.94 (24.17) 77.06 (24.80)  
BSI Subscales        
Depression 1.41 (1.45) 1.96 (1.09)   1.57 (1.06) 2.39 (1.29) * 
Global Severity Index 1.34 (1.00) 1.65 (0.82)   1.51 (0.85) 1.73 (0.91)  
Social and Occupational 
Functioning Assessment Scale 
60.95 (11.22) 50.14 (9.20) ***  55.15 (12.59) 53.28 (8.70)  
Global Assessment of Function 58.47 (10.77) 50.07 (8.71) ***  53.66 (10.40) 52.41 (10.36)  
OTI: Opiate Treatment Index, values in square brackets show mean usage by users; AUDIT: Alcohol Use Disorders Identification Test; CUDIT-R: 
Cannabis Use Disorders Identification Test – Revised; BSI: Brief Symptom Inventory. Statistical comparisons: χ2 for categorical variables, and t-
tests for continuous variables. *p<.05; **p<.01, ***p<.001; n/a for variables associated with sub-group definitions. 
  
Urban Site: Newcastle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. DEPTh trial recruitment at the urban and rural sites. 
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